New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Radiotherapy boost can cut breast cancer treatment time by at least one week, finds clinical trial

Radiotherapy boost can cut breast cancer treatment time by at least one week, finds clinical trial

by Craig Brierley,University of CambridgeCredit: Pixabay/CC0 Public DomainTreatment times for radiotherapy could be reduced for some early breast cancer patients, according to a trial led by Uni
World medicine December 12,2023
Radiotherapy boost can cut breast cancer treatment time by at least one week, finds clinical trial

Radiotherapy boost can cut breast cancer treatment time by at least one week, finds clinical trial

by Craig Brierley,University of CambridgeCredit: Pixabay/CC0 Public DomainTreatment times for radiotherapy could be reduced for some early breast cancer patients, according to a trial led by Uni
World medicine December 12,2023
Immunotherapy for 'difficult to treat' lung cancer patients improves long-term survival: Clinical trial

Immunotherapy for 'difficult to treat' lung cancer patients improves long-term survival: Clinical trial

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA global study, led by UCL and UCLH, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival
World medicine December 12,2023
Immunotherapy for 'difficult to treat' lung cancer patients improves long-term survival: Clinical trial

Immunotherapy for 'difficult to treat' lung cancer patients improves long-term survival: Clinical trial

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA global study, led by UCL and UCLH, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival
World medicine December 12,2023
Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

byMedical College of WisconsinCredit: Pixabay/CC0 Public DomainIn a multi-center phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers across the globe, including the
World medicine December 12,2023
Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

Clinical trial tests pirtobrutinib for patients previously treated for mantle cell lymphoma

byMedical College of WisconsinCredit: Pixabay/CC0 Public DomainIn a multi-center phase 1 and 2 trial (BRUIN, NCT03740529), researchers from leading cancer centers across the globe, including the
World medicine December 12,2023
Clinical screening can identify fear of cancer recurrence

Clinical screening can identify fear of cancer recurrence

by Ben Knight,University of New South WalesCredit: AI-generated imageFear of cancer recurrence (FCR) is one of the most common and distressing concerns cancer survivors have. For many, it can be
World medicine December 12,2023
Clinical screening can identify fear of cancer recurrence

Clinical screening can identify fear of cancer recurrence

by Ben Knight,University of New South WalesCredit: AI-generated imageFear of cancer recurrence (FCR) is one of the most common and distressing concerns cancer survivors have. For many, it can be
World medicine December 12,2023
Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

byChildren's Hospital of PhiladelphiaRepresentative images from subject 3 who had both measurable and MIBG-evaluable neuroblastoma and an overall central radiology reviewed PR from cycles 3
World medicine December 12,2023
Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

Two studies find role for alternative lengthening of telomeres in treatment-resistant tumors

byChildren's Hospital of PhiladelphiaRepresentative images from subject 3 who had both measurable and MIBG-evaluable neuroblastoma and an overall central radiology reviewed PR from cycles 3
World medicine December 12,2023
Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

byBritish Medical JournalCredit: CC0 Public DomainGood cardiorespiratory fitness when young is associated with up to a 40% lower risk of developing 9 specific cancers later on—at least in men—su
World medicine December 12,2023
Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

Good cardiorespiratory fitness associated with up to 40% lower risk of 9 cancers

byBritish Medical JournalCredit: CC0 Public DomainGood cardiorespiratory fitness when young is associated with up to a 40% lower risk of developing 9 specific cancers later on—at least in men—su
World medicine December 12,2023
Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

by Instituto de Medicina MolecularGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101120Breast cancer is a heterogeneous disease, but 70% of cases are char
World medicine December 12,2023
Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

Combination therapy can prevent resistance to treatment in hormone responsive metastatic breast cancer patients

by Instituto de Medicina MolecularGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101120Breast cancer is a heterogeneous disease, but 70% of cases are char
World medicine December 12,2023
New leukemia treatment-response 'crystal ball' discovered using AI

New leukemia treatment-response 'crystal ball' discovered using AI

by Federico Graciano,Duke-NUS Medical SchoolCredit: Unsplash/CC0 Public DomainScientists at Duke-NUS Medical School, A*STAR's Genome Institute of Singapore (GIS), Singapore General Hospital
World medicine December 12,2023
New leukemia treatment-response 'crystal ball' discovered using AI

New leukemia treatment-response 'crystal ball' discovered using AI

by Federico Graciano,Duke-NUS Medical SchoolCredit: Unsplash/CC0 Public DomainScientists at Duke-NUS Medical School, A*STAR's Genome Institute of Singapore (GIS), Singapore General Hospital
World medicine December 12,2023
Using the immune system to stop ovarian cancer

Using the immune system to stop ovarian cancer

byHudson Institute of Medical ResearchSuppression of epithelial IFNε in HGSOC and anti-tumor properties.a,b, IHC staining of human FT from two healthy women using rabbit anti-human IFNε (m
World medicine December 12,2023
Using the immune system to stop ovarian cancer

Using the immune system to stop ovarian cancer

byHudson Institute of Medical ResearchSuppression of epithelial IFNε in HGSOC and anti-tumor properties.a,b, IHC staining of human FT from two healthy women using rabbit anti-human IFNε (m
World medicine December 12,2023
Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

byScience China Pressa) Cell uptake efficiency of Cy5-XQ-2d, Cy5-S-XQ-2d, Cy5-MFSX, and Cy5-MFC by PL45 cells. b) The ratio of Geometric Mean Fluorescence Intensity to Cy5-MFC for Cy5-XQ-2d, Cy5
World medicine December 12,2023
Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

Leveraging phosphorothioate backbone modification to optimize aptamer-drug conjugates for therapeutic agent delivery

byScience China Pressa) Cell uptake efficiency of Cy5-XQ-2d, Cy5-S-XQ-2d, Cy5-MFSX, and Cy5-MFC by PL45 cells. b) The ratio of Geometric Mean Fluorescence Intensity to Cy5-MFC for Cy5-XQ-2d, Cy5
World medicine December 12,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com